ArticleJournal of comparative effectiveness research2023

Cost-effectiveness of weekly gastro-resistant risedronate 35 mg, compared with weekly alendronate 70 mg tablets, in the treatment of postmenopausal osteoporosis in Spain.

Enrique Casado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.